“Biobased products are perfect examples of the shift towards a circular economy as they are made from renewable raw materials rather than from finite fossil carbon sources. However, the link between the bioeconomy and the circular economy is not always made and we need it to be better recognised in order to ensure that the right supportive measures are put in place to help enable this transition. This is why we are focusing on the circular economy in anticipation of the European Commission’s proposal which is due out towards the end of this year”. To say it in this exclusive interview with Il Bioeconomista is Nathalie Moll, Secretary General of EuropaBio, the European Association for Bioindustries. With Moll we talk about bioeconomy, biotechnology, circular economy and EFIB, the European Forum for Industrial Biotechnology and the Bioeconomy, which will take place next October 27-29 in Brussels.
EFIB returns to Brussels. From 27 to 29 October the European Forum for Industrial Biotechnology and the Biobased Economy (EFIB) returns to Europe’s capital, where it was first launched 7 years ago, taking place at the Square, Brussels meeting center. Since then, the event has grown tenfold in size but remains true to its goal of providing the premier meeting place for business and policy throughout the biobased value chain.
Two companies have been announced as winners of EuropaBio’s Most Innovative Biotech SME Award 2014. The award ceremony took place yesterday in Brussels, as part of the second edition of the European Biotech Week.
Everything is ready in Reims, France, to host the seventh edition of Efib. EuropaBio, the European Association for Bioindustries, and Smithers Rapra in association with IAR-Pole return in 2014 from 30 September to 2 October to deliver the European Forum for Industrial Biotechnology and the Biobased Economy. EFIB is the premier market place for the European Biobased economy. Over 800 professionals, working within the dynamic and sustainable biobased industries sector, will be in attendance.
“In order to be commercially successful it is essential to facilitate the introduction of innovative biobased products on the market. This means ensuring the implementation of the Priority Recommendations from the Lead Market Initiative, to boost the uptake of innovative biobased products on the European market. A good example from the US, in this respect, is the Biopreferred programme, which was established to ensure that US policy is aiding sustainable biobased industries to have a competitive edge through public procurement initiatives. Additionally, we need to foster investments through combined financing”. To say this – in this exclusive interview with Il Bioeconomista – is Nathalie Moll, Secretary General of EuropaBio, the European Association for Bioindustries. With Moll we discuss about bioeconomy in Europe and the next edition of EFIB, the European Forum for Industrial Biotechnology and Bio-based economy, which will take place in Reims (France) from 30 September to 2 October. “This years’s EFIB – says Moll – will provide the forum for dynamic discussion around the year’s biggest and best joint ventures, with high profile consumer brands. It will also provide a snapshot of how policy is being put into practice through the most significant developments in scale up of commercial biorefineries around the world”.
EuropaBio and Smithers Rapra, in association with IAR, unveil the highly-anticipated agenda for the European Forum for Industrial Biotechnology (EFIB) from 1-2 October 2014 taking place in Reims, the heart of Champagne-Ardenne (France). Committed to creating a forum to address opportunities and challenges for the biobased economy, EFIB is consistent in attracting an unrivalled calibre of speakers from across the fields of both policy and business. This year’s high level plenary includes a French ministerial address from this year’s host nation, complemented by the European Commission’s take on the future of the European biobased economy. Followed by a discussion on shale gas and how it is impacting investments and market development in petrochemical and biobased value chains, featuring representatives from Shell and European Bioplastics.
Everything is ready in Brussels to host EFIB, the European Forum for Industrial Biotechnology and Bio-based economy organized by EuropaBio, the European Association for Bioindustries, and Smithers Rapra which will take place from September 30 to October 2, during the European Biotech Week (from September 30 to October 4), when events across Europe will celebrate biotechnology, an innovative and vibrant sector launched by the 1953 discovery of the DNA molecule, sixty years ago.
“We believe that EFIB (European Forum for Industrial Biotechnology and Bio-based Economy, editor’s note), taking place during the first European Biotech Week, contributes to increase the awareness of Europeans to the bioeconomy.” To say it is Nathalie Moll, Secretary General of EuropaBio, The European Association for Bioindustries, one of the organizers, with Smithers Rapra, of the event which will be held in Brussels from 30 September to 2 October. In this interview with Il Bioeconomista, Moll talks about EFIB – “a single platform for European business leaders, innovators and policymakers to meet, discuss and shape the future of the bioeconomy” – and the latest development of European Bioeconomy, focusing on the Public Private Partnership for Biobased industries (Bridge), “a multisector initiative whose vision is that of a society and economy which increasingly makes everyday products, such as food, feed, textiles, chemicals and fuels, from locally sourced biomass and wastes, rather than from fossil fuels.”